Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes

Overview of attention for article published in Frontiers in immunology, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 89 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Type 1 diabetes: Drug delays onset by 2 years

Medical News Today, 10 Jun 2019

New research finds that the immunotherapy drug teplizumab delays the onset of type 1 diabetes by 2 years, on average, in high-ris…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.